Advertisement

Topics

eTheRNA initiates Phase Ib trial of TriMix-MEL for metastatic melanoma

19:00 EDT 2 Jul 2017 | Net Resources International

Belgium-based cancer therapies developer eTheRNA Immunotherapies has initiated a Phase Ib clinical trial of TriMix-MEL (ECI-006) to treat patients with metastatic melanoma.

Original Article: eTheRNA initiates Phase Ib trial of TriMix-MEL for metastatic melanoma

NEXT ARTICLE

More From BioPortfolio on "eTheRNA initiates Phase Ib trial of TriMix-MEL for metastatic melanoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...